Current Medical Practice and the Food and Drug Administration
| Autor: | Michael Weintraub, Gregory R. Mundy, Louis Lasagna, John M. Mazzullo, Lawrence Fleckenstein, Pavur R Sundaresan |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
Drug
medicine.medical_specialty business.industry media_common.quotation_subject Alternative medicine Allopurinol General Medicine Propranolol Food and drug administration Propranolol Hydrochloride medicine Medical prescription Intensive care medicine business media_common Medical literature medicine.drug |
| Zdroj: | JAMA. 229:1744 |
| ISSN: | 0098-7484 |
| DOI: | 10.1001/jama.1974.03230510018015 |
| Popis: | The manner of use of three prescription drugs for hospitalized patients (cephalexin, allopurinol, and propranolol hydrochloride) was compared with the labeling recommendations that are approved by the Food and Drug Administration (FDA). Each drug was prescribed frequently for therapeutic indications not mentioned in the approved labeling (cephalexin in 78.3% of cases, allopurinol in 57.1%, and propranolol in 64.7%). Thus, a gap has developed between current medical practice and FDA-approved recommendations for therapeutic use. We suggest that for cephalexin and allopurinol, the FDA-approved recommendations agreed with the current medical literature, and the prescribing habits of physicians were inappropriate. With propranolol, however, the FDA-approved recommendations were lagging behind both good medical practice and the current medical literature. The implications of these findings are discussed with respect to prescribing habits and drug regulation. ( JAMA 229:1744-1748, 1974) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|